Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2010
11/18/2010WO2010132886A1 Compositions and methods relating to xmrv-related diseases and conditions
11/18/2010WO2010132862A1 Microfluidic method and system for isolating particles from biological fluid
11/18/2010WO2010132847A1 Platform technologies for spontaneously occurring diseases
11/18/2010WO2010132817A1 Carcinoma diagnosis and treatments, based on odc1 genotype
11/18/2010WO2010132795A2 Systems, devices, and methods for specific capture and release of biological sample components
11/18/2010WO2010132758A2 Ospc-based diagnostic test for lyme disease
11/18/2010WO2010132723A1 Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
11/18/2010WO2010132610A2 Thermoplastic substrates with wrinkled metallic surfaces for chemical and biological sensing
11/18/2010WO2010132581A2 Vessel coating and inspection
11/18/2010WO2010132532A1 B cell surface reactive antibodies
11/18/2010WO2010132486A2 Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
11/18/2010WO2010132481A1 Human nt-pro b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
11/18/2010WO2010132479A2 Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
11/18/2010WO2010132459A2 Biomarkers for assessment of age-related macular degeneration
11/18/2010WO2010132453A2 Methods and compositions for analyte detection
11/18/2010WO2010132447A2 Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
11/18/2010WO2010132363A1 Method of protein nanostructure fabrication
11/18/2010WO2010132354A1 Method for reducing loss of electromagnetic radiation in detection applications
11/18/2010WO2010132263A2 Wireless based marine pathogens detection system
11/18/2010WO2010132208A2 Diagnostic methods for liver disorders
11/18/2010WO2010132179A1 Environmental control of fluid samples, calibration, and detection of concentration levels
11/18/2010WO2010132097A2 Compositions and methods for pest control
11/18/2010WO2010131984A1 Markers for detection of gastric cancer
11/18/2010WO2010131917A2 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
11/18/2010WO2010131826A1 Method for screening osteopontin inhibitor and inhibitor prepared thereby
11/18/2010WO2010131717A1 Prion protein structure transformation inhibitor and utilization of same
11/18/2010WO2010131704A1 Test agent for visceral obesity and use thereof
11/18/2010WO2010131703A1 NOVEL PPARγ PROMOTER SEQUENCE AND USE APPLICATION THEREOF
11/18/2010WO2010131663A1 Oxamide derivative
11/18/2010WO2010131660A1 Method for measurement of equol in biological sample by immunoassay, kit for the measurement, and method for determination of equol production ability of subject
11/18/2010WO2010131641A1 Method for determination of condition of cell
11/18/2010WO2010131590A1 Diagnostic agent and therapeutic agent for tumors
11/18/2010WO2010131491A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
11/18/2010WO2010131195A1 Phosphodiesterase 4d7 as prostate cancer marker
11/18/2010WO2010131194A1 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer
11/18/2010WO2010131193A1 Phosphodiesterase 9a as prostate cancer marker
11/18/2010WO2010131140A1 Biological sample collection device
11/18/2010WO2010131127A2 Absorbent articles capable of indicating the presence of urinary tract infections
11/18/2010WO2010131080A1 A method for predicting the therapeutic responsiveness of a patient to a medical treatment with an egfr inhibitor
11/18/2010WO2010131024A1 Archaeological dating technique
11/18/2010WO2010130985A1 Cmybp-c and mlc2 as diagnostic markers of cardiac injury
11/18/2010WO2010130946A1 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
11/18/2010WO2010130861A1 Non-invasive device for detecting metabolites in sweat
11/18/2010WO2010130839A1 Cybp as a marker of lung cancer
11/18/2010WO2010130782A1 Use of the gtpase rab27b to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer
11/18/2010WO2010130748A1 Method for identifying inhibitors against dengue virus
11/18/2010WO2010130474A1 Device for determining a property of a cylindrical test specimen
11/18/2010WO2010130055A1 Closure, containing apparatus, and method of using same
11/18/2010WO2010130045A1 High sensitivity plasmonic structures for use in surface plasmon resonance sensors and method of fabrication thereof
11/18/2010WO2010129987A1 Novel receptor hetero-dimers/-oligomers
11/18/2010WO2010123594A3 Device for filtration of fluids there through and accompanying method
11/18/2010WO2010109363A3 Gas sensing using ultrasound
11/18/2010WO2010106431A3 High affinity t-cell receptor-like ny-eso-1 peptide antibodies, methods, and uses thereof
11/18/2010WO2010103308A3 Optical cell assembly, cartridge and apparatus
11/18/2010WO2010099979A3 Uses and methods for the identification of a cytoprotective compound involving gp130 or lifralpha
11/18/2010WO2010099364A3 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
11/18/2010WO2010091236A9 Methods and compositions for diagnosis and prognosis of renal injury and failure
11/18/2010WO2010090471A3 Novel diagnostic marker for type 1 diabetes mellitus
11/18/2010WO2010088219A3 Reusable biosensor platform
11/18/2010WO2010085775A3 System, method and computer-accessible medium for providing wide-field superresolution microscopy
11/18/2010WO2010085387A3 Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
11/18/2010WO2010080978A3 Pre-depletion of leukocytes in whole blood samples prior to the capture of whole blood sample components
11/18/2010WO2010080617A3 Detecting and sorting methylated dna using a synthetic nanopore
11/18/2010WO2010078290A3 System for screening agonists/antagonists of cellular signaling pathways
11/18/2010WO2010075360A3 Methods for detection of sepsis
11/18/2010WO2010071817A3 Characterization of o-linked glycans
11/18/2010WO2010069605A3 Oxidized cardiolipin as a novel pro-inflammatory factor
11/18/2010WO2010042525A9 Ovarian cancer biomarkers and uses thereof
11/18/2010WO2010041349A8 Marker for estimating the diagnosis of cervical adenocarcinoma or for estimating the prognosis of cervical cancer
11/18/2010WO2010034670A3 Host cell kinases as targets for antiviral therapies against hcv infection
11/18/2010WO2010025216A9 System and methods for measuring biomarker profiles
11/18/2010WO2009014761A9 Method for predicting response to tamoxifen
11/18/2010WO2007027906A3 Reagents for the detection of protein phosphorylation in leukemia signaling pathways
11/18/2010US20100293241 Internet/intranet-connected apparatus
11/18/2010US20100292975 Information processing system using base sequence relevant information
11/18/2010US20100292932 Method and apparatus for estimating features of target materials by using kinetic change information
11/18/2010US20100292930 Methods for generating databases and databases for identifying polymorphic genetic markers
11/18/2010US20100292456 Rna interference mediating small rna molecules
11/18/2010US20100292451 Method for diagnosing selected adenocarcinomas
11/18/2010US20100292348 Detection of methylated dna and dna mutations
11/18/2010US20100292331 Biomarkers for Prostate Cancer and Methods Using the Same
11/18/2010US20100292302 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity
11/18/2010US20100292298 Method and reagents for treating hepatic fibrosis and inflammation
11/18/2010US20100292200 Methods for Modulating Apoptosis in Platelets
11/18/2010US20100292179 Target
11/18/2010US20100292171 Competitive Regulation of Hepcidin mRNA by Soluble and Cell-Associated Hemojuvelin
11/18/2010US20100292170 Methods for diagnosing and treating pelvic pain disorders via beta-catenin
11/18/2010US20100292162 Socs-3 promoter methylation in cancer
11/18/2010US20100292154 Protein profile for osteoarthritis
11/18/2010US20100292152 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
11/18/2010US20100292149 Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease
11/18/2010US20100292147 Identification of the hepcidin binding site on ferroportin
11/18/2010US20100292131 Biomarkers and methods for diagnosing, predicting and/or prognosing sepsis and uses thereof
11/18/2010US20100292129 Methods and Compositions for Enhancing Proteasome Activity
11/18/2010US20100292104 Photoswitchable Method for the Ordered Attachment of Proteins to Surfaces
11/18/2010US20100292097 Complexity Management of Genomic DNA
11/18/2010US20100292096 Strain and species-specific borrelia protein array
11/18/2010US20100292095 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
11/18/2010US20100292091 Mara family helix-turn-helix domains and their methods of use
11/18/2010US20100292090 Prognostic markers and therapeutic targets for lung cancer
1 ... 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 ... 3937